Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds

Xenobiotica

Volumn 29, Issue 12, 1999, Pages 1191-1202

  Nakajima, M ^a   Suzuki, M ^a   Yamaji, R ^a   Takashina, H ^b   Shimada, N ^c   Yamazaki, H ^a   Yokoi, T ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

^c DAIICHI PURE CHEMICALS CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; BENZOTHIAZINE DERIVATIVE; BUFURALOL; CHLORZOXAZONE; COUMARIN; CYTOCHROME P450; ETHOXYRESORUFIN; MEPHENYTOIN; MICROSOME ENZYME; TESTOSTERONE; WARFARIN;

ARTICLE; B LYMPHOBLAST; CONTROLLED STUDY; DEALKYLATION; DRUG HYDROXYLATION; ENZYME INACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYDROXYLATION; INHIBITION KINETICS;

EID: 0033377106     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599237877     Document Type: Article

References (35)

1. Carriere, V., Goasduff, T., Ratanasavanh, D., Morel, F., Gautier, J.-C., Guillouzo, A., Beaune, P. and Berthou, F., 1993, Both cytochrome P450 2E1 and 1A1 are involved in the metabolism of chlorzoxazone. Chemical Research in Toxicology, 6, 852-857.
2. Casida, J. E., 1970, Mixed function oxidase involvement in the biochemistry of insecticide synergists. Journal of Agricultural and Food Chemistry, 18, 753-772.
3. Chiba, K., Kobayashi, K., Manabe, K., Tani, M., Kamataki, T. and Ishizaki, T., 1993, Odative metabolism of omeprazole in human liver microsomes: Cosegregation with S-mephenytoin 4′-hydroxylation. Journal of Pharmacology and Experimental Therapeutics, 266, 52-59.
4. Chiba, M., Nishime, J. A. and Lin, J. H., 1995, Potent and selective inactivation of human liver microsomal cytochrome P-450 isoforms by L-754,394, an investigational human immune deficiency virus protease inhibitor. Journal of Pharmacology and Experimental Therapeutics, 275, 1527-1534.
5. Dahl, A. R. and Hodgson, E., 1979, The interaction of aliphatic analogs of methylenedioxyphenyl compounds with cytochromes P-450 and P-420. Chemico-Biological Interactions, 27, 163-175.
6. Ekins, S., Vandenbranden, M., Ring, B. J., Gillespie, J. S., Yang, T. J., Gelboin, H. V. and Wrighton, S. A., 1998, Further characterization of the expression in liver and catalytic activity of CYP2B6. Journal of Pharmacology and Experimental Therapeutics, 286, 1253-1259.
7. Elcombe, C. R., Bridges, J. W., Nimmo-Smith, R. H. and Werringloer, J., 1975, Cumene hydroperoxide-mediated formation of inhibited complexes of methylenedioxyphenyl compounds with cytochrome P-450. Biochemical Society Transactions, 3, 967-970.
8. Eugster, H.-P., Probst, M., Würgler, F. E., and Sengstag, C., 1993, Caffeine, estradiol, and progesterone interact with human CYP1A1 and CYP1A2. Evidence from cDNA-directed expression in Saccharomyces cerevisiae. Drug Metabolism and Disposition, 21, 43-49.
9. Franklin, M. R., 1971, The enzymic function of a methylene dioxyphenyl derivative exhibiting an isocyanide-like spectrum with reduced cytochrome P-450 in hepatic microsomes. Xenobiotica, 1, 581-591.
10. Guengerich, F. P., 1990, Mechanism-based inactivation of human liver microsomal cytochrome P-450 IIIA4 by gestodene. Chemical Research in Toxicology, 3, 363-371.
11. Guengerich, F. P., 1992, Characterization of human cytochrome P-450 enzymes. FASEB Journal, 6, 745-748.
12. Hansch, C., 1968, The use of homolytic, steric, and hydrophobic constants in a structure-activity study of 1,3-benzodioxole synergists. Journal of Medicinal Chemistry, 11, 920-924.
13. Hennessy, D. J. 1965, Hydride-transferring ability of methylenedioxybenzenes as a basis of synergistic activity. Journal of Agricultural and Food Chemistry, 13, 218-220.
14. Hodgson, E. and Philpot, R. M., 1974, Interaction of methylene dioxyphenol (1,3-benzodioxole) compounds with enzymes and their effects on mammals. Drug Metabolism Reviews, 3, 231-301.
15. Hodgson, E., Philpot, R. M., Baker, R. C. and Mailman, R. B., 1973, Effects of synergist on drug metabolism. Drug Metabolism and Disposition, 1, 391-401.
16. Ioannides, C., Delaforge, M. and Parke, D. V., 1981, Safrole: Its metabolism, carcinogenicity and interactions with cytochrome P-450. Food and Cosmetics Toxicology, 19, 657-666.
17. Kamiensky, F. X. and Murphy, S. D., 1971, Biphasic effects of methylenedioxyphenyl synergists on the action of hexobarbital and organophosphate insecticides in mice. Toxicology and Applied Pharmacology, 18, 883-894.
18. Kaminsky, L. S. and Zhang, Z.-Y., 1997, Human P450 metabolism of warfarin. Pharmacology and Therapeutics, 73, 67-74.
19. Kronbach, T., Mathys, D., Gut, J., Catin, T. and Meyer, U. A., 1987, High-performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver. Analytical Biochemistry, 162, 24-32.
20. Kunze, K. L. and Trager, W. F., 1993, Isoform-selective mechanism-based inhibition of human cytochrome P-4501A2 by furafylline. Chemical Research in Toxicology, 6, 649-656.
21. Mansuy, D., Battion, J. P., Chottard, J. C. and Ullrich, V., 1979, Preparation of a porphyrin iron carbene model for cytochrome P-450 complexes obtained upon metabolic activation of the insecticide synergists of the 1,3-benzodioxole series. Journal of the American Chemical Society, 101, 3971-3972.
22. Murray, M., Wilkinson, C. F. and Dube, C. E., 1983a, Effects of dihydrosafrole on cytochrome P-450 and drug oxidation in hepatic microsomes from control and induced rats. Toxicology and Applied Pharmacology, 68, 66-76.
23. Murray, M., Wilkinson, C. F., Marcus, C. and Dube, C. E., 1983b, Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo. Molecular Pharmacology, 24, 129-136.
24. Murray, M., Hetnarski, K. and Wilkinson, C. F., 1985, Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes. Xenobiotica, 15, 369-379.
25. Nakajima, M., Ohyama, K., Nakamura, S., Shimada, N., Yamazaki, H. and Yokoi, T., 1999, Inhibitory effects of azelastine and its metabolites on drug oxidation catalyzed by human cytochrome P450 enzymes. Drug Metabolism and Disposition, 27, 792-797.
26. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C. and Nebert, D. W., 1996, P450 superfamily; update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42.
27. Rendic, S. and Di Carlo, F. J., 1997, Human cytochrome P450 enzymes: A status report summarizing their reactions, substrate, inducers, and inhibitor. Drug Metabolism Reviews, 29, 413-580.
28. Silverman, R. B., 1988, Mechanism-based enzyme inactivation. In Chemistry and Enzymology (Boca Raton: CRC Press), Vols 1 and 2, pp. 3-16.
29. Spatzenegger, M. and Jaeger, W., 1995, Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metabolism Review, 27, 397-417.
30. Ullrich, V. and Schnabel, K. H., 1973, Formation and ligand binding of the fluorenyl carbanion by hepatic cytochrome P-450. Archives of Biochemistry and Biophysics, 159, 240-248.
31. Waley, S. G., 1985, Kinetics of suicide substrates. Practical procedures for determining parameters. Biochemical Journal, 227, 843-849.
32. Waxman, D. J., Attisano, C., Guengerich, F. P. and Lapenson, D. P., 1988, Human liver microsomal steroid metabolism: Identification of the major microsomal steroid hormone 6β-hydroxylase cytochrome P-450 enzyme. Archives of Biochemistry and Biophysics, 263, 424-436.
33. Wilkinson, C. F., Murray, M. and Marcus, C. B., 1984, Interaction of methylenedioxyphenyl compounds with cytochrome P-450 and effects on microsomal oxidation. In Reviews in Biochemical Toxicology, edited by E. Hodgson, J. R. Bend and R. M. Philpot (Amsterdam: Elsevier), 6, pp. 27-63.
34. Yamazaki, H., Guo, Z. and Guengerich, F. P., 1995, Selectivity of cytochrome P4502E1 in chlorzoxazone 6-hydroxylation. Drug Metabolism and Disposition, 23, 438-440.
35. Yun, C.-H., Shimada, T. and Guengerich, F. P., 1991, Purification and characterization of human liver microsomal cytochrome P-4502A6. Molecular Pharmacology, 40, 679-685.